Biogen CEO scoops up $2.3M Back Bay condo

The Cambridge drug giant appointed Michel Vounatsos to replace longtime CEO George Scangos in January 2017.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.